Ameet Sarpatwari

Harvard Medical School

Instructor in Medicine

25 Shattuck St

Boston, MA 02115

United States

Brigham and Women's Hospital

Associate Epidemiologist

Boston, MA 02115

United States

  • Harvard Medical School

  • Brigham and Women's Hospital

SCHOLARLY PAPERS

8

DOWNLOADS

368

TOTAL CITATIONS

0

Scholarly Papers (8)

Actions:
Email selected abstracts
1.

Mifepristone, Preemption, and Public Health Federalism

Ohio State Legal Studies Research Paper No. 739, Drug Enforcement and Policy Center, November 2022, Forthcoming in the Journal of Law and the Biosciences
Number of pages: 48 Posted: 08 Nov 2022
Patricia J. Zettler, Annamarie Beckmeyer, Beatrice L. Brown and Ameet Sarpatwari
Ohio State University (OSU) - Michael E. Moritz College of Law, Ohio State University (OSU) - College of Medicine, Harvard University - Harvard Medical School and Harvard Medical School
Downloads 185 (330,578)

Abstract:

Loading...

2.

The 340B Drug Pricing Program: Litigation, Administration, and Reform

Oklahoma Law Review, Forthcoming
Number of pages: 46 Posted: 28 Sep 2023
Ryan Knox and Ameet Sarpatwari
Harvard-MIT Center for Regulatory Science and Harvard Medical School
Downloads 84 (601,474)

Abstract:

Loading...

Health Law, Drug Pricing, Access to Medicines, Administrative Law, Food & Drug Law, Pharmaceutical Policy

3.

Crowdsourcing Public Health Experiments: A Response to Jonathan Darrow's Crowdsourcing Clinical Trials

98 Minnesota Law Review 2326 (2014), Arizona Legal Studies Discussion Paper No. 14-14
Number of pages: 21 Posted: 26 May 2014 Last Revised: 27 May 2014
Ameet Sarpatwari, Christopher T. Robertson, David V. Yokum and Keith A. Joiner
Harvard Medical School, Boston University, University of Arizona - James E. Rogers College of Law and University of Arizona - College of Medicine
Downloads 71 (660,003)

Abstract:

Loading...

crowdsourcing, clinical trials, CCT, ethics, informed consent, observational studies, public health

4.

Just Say No: The Case Against the Reclassification of Buprenorphine

University of Maryland Law Journal of Race, Religion, Gender and Class, Volume 12, Issue 2, Article 5, 2012
Number of pages: 20 Posted: 03 Sep 2014
Ameet Sarpatwari
Harvard Medical School
Downloads 28 (960,679)

Abstract:

Loading...

5.

Patent Portfolios Protecting 10 Top-Selling Prescription Drugs

WVU College of Law Research Paper No. 2024-026, 10.1001/jamainternmed.2024.0836
Posted: 16 Sep 2024
Caroline Harrow, Sarah Gabriele, S. Sean Tu, Ameet Sarpatwari and Aaron S. Kesselheim
Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, West Virginia University College of Law, Harvard Medical School and Brigham and Women's Hospital/Harvard Medical School

Abstract:

Loading...

patent law, pharmaceutical patents, FDA, patent thickets, generic drugs, biosimilar drugs

6.

Patents on Risk Evaluation and Mitigation Strategies for Prescription Drugs and Generic Competition

JAMA, Vol. 331(11), 976-978 (2024), WVU College of Law Research Paper No. 2024-022
Posted: 23 Aug 2024
Ameet Sarpatwari, Sajeev Kohli, S. Sean Tu and Aaron S. Kesselheim
Harvard Medical School, Harvard College, West Virginia University College of Law and Brigham and Women's Hospital/Harvard Medical School

Abstract:

Loading...

patent law, FDA, pharmaceutical patents, risk evaluation and mitigation strategies

7.

Frequency of Approval and Marketing of Biosimilars with a Skinny Label and Associated Medicare Savings

JAMA Internal Medicine, Vol. 183(1), p. 82-84 (2023), WVU College of Law Research Paper No. 2024-030
Posted: 22 Aug 2024
Alexander Egilman, Victor Van de Wiele, Benjamin N. Rome, Jonathan J. Darrow, S. Sean Tu, Aaron S. Kesselheim and Ameet Sarpatwari
Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, University of Cambridge, Faculty of Law, Independent, Harvard Medical School, West Virginia University College of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard Medical School

Abstract:

Loading...

generic drugs, biosimilar, biologic drugs, FDA, drug patents, Medicare

8.

A 'Method of Use' to Prevent Generic and Biosimilar Market Entry

New England Journal of Medicine, Vol. 388, p. 483-485, WVU College of Law Research Paper No. 2023-009
Posted: 08 May 2023
S. Sean Tu and Ameet Sarpatwari
West Virginia University College of Law and Harvard Medical School

Abstract:

Loading...

patent law, patent thicket, pharmaceutical patents, generic drugs, method of use patents